BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17172120)

  • 1. [Correlation between human herpesvirus 6 activation and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang LR; Dong LJ; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):507-10. PubMed ID: 17172120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human herpesvirus 7 infection in patients after allogeneic hematopoietic stem cell transplantation].
    Wang LR; Dong LJ; Lu DP
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2113-6. PubMed ID: 17988530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
    Wang LR; Dong LJ; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
    Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
    Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
    Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
    Tormo N; Solano C; de la Cámara R; Garcia-Noblejas A; Cardeñoso L; Clari MA; Nieto J; López J; Hernández-Boluda JC; Remigia MJ; Benet I; Navarro D
    Biol Blood Marrow Transplant; 2010 May; 16(5):653-61. PubMed ID: 20005968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients.
    Wang FZ; Larsson K; Linde A; Ljungman P
    Bone Marrow Transplant; 2002 Oct; 30(8):521-6. PubMed ID: 12379892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
    Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
    Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
    Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
    Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
    J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of beta-herpesviruses in allogenic stem cell recipients by quantitative real-time PCR.
    Sassenscheidt J; Rohayem J; Illmer T; Bandt D
    J Virol Methods; 2006 Dec; 138(1-2):40-8. PubMed ID: 16956672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.